Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001228083 | SCV001400468 | pathogenic | not provided | 2024-04-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ile1557Serfs*17) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (rs747891004, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 955440). For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV001228083 | SCV004238794 | likely pathogenic | not provided | 2023-05-23 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004570563 | SCV005055680 | pathogenic | Retinitis pigmentosa 39 | 2024-03-23 | criteria provided, single submitter | clinical testing |